Sources

10 Total Sources

GLP-1 Drugs Reshape Obesity Care, Cutting Cardiac Events 20% as New Oral Options Expand

Stanford Medical Center Report2d ago

GLP-1 Agonists Transform Obesity and Diabetes Treatment, Expanding Uses

What Happens After You Stop a GLP-1? New Noom Data Suggest Habits May Help Weight Loss Last

FoodNavigator-USA.com1d ago

CMS GLP-1 pilot expands access for seniors, impacts food industry

Trump low-cost GLP-1 plan a likely boost for Eli Lilly, Novo Nordisk | STAT

Nature.com1d ago

Strengthening the metabolic alliance: exercise as an essential partner of obesity pharmacotherapy | Nature Reviews Endocrinology

Emerging research reveals GLP-1 drugs like Ozempic may combat diseases beyond obesity, including cancer and addiction, though caution is advised with unverified claims.

sciencedirect.com2d ago

Targeting the GLP-1 receptor pathways for dual management of obesity and depression - ScienceDirect

Instagram2d ago

Danish drugmakers transformed GLP1 therapy into pills that may replace many injections soon. That is a deceptively big deal. A medicine that once meant needles and weekly schedules is being redesigned into

Physician's Weekly2d ago

Combining High Protein Diet With GLP-1 and GIP Treatment Improves Outcomes | www.PhysiciansWeekly.com

ACP issues guidance on medications for obesity, overweight